News for Healthier Living

Harrington Discovery Institute Researchers Identify New Drug Targets for Hard-to-Treat Cancers

* Despite impressive innovations in medicine, most advanced-stage cancers still carry a grim prognosis. * Developing more effective treatments requires a deeper understanding of the cellular processes that drive the formation and growth of common cancers. * Growth factor receptors are well-established drivers of many cancers, and many modern therapies target these receptors effectively. * However, cancers in most patients eventually become resistant to existing drugs. * By identifying new cellular components required for growth factor signaling, researchers have uncovered a new class of therapeutic targets.

May 19, 2026


May 19 2026

May 18 2026

May 17 2026

May 16 2026

May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026